News | Lung Cancer | December 19, 2019

Hoag Introduces Safer, More Powerful Tool in the Fight Against Lung Cancer

The Hoag Family Cancer Institute is the first in Southern California to offer Ion robot-assisted bronchoscopy

 

 Cancer in lung Siemens PET Biograph mCT Flow Lung

December 19, 2019 — Hoag hopes to turn the tables on lung cancer by becoming one of select hospitals in the nation, and the first in Southern California, to adopt the Ion robot-assisted bronchoscopy, a technology that drastically improves accuracy and precision of lung cancer biopsy, while also providing an improved patient experience.   

The Ion robotic-assisted bronchoscopy is the newest technology available for lung cancer diagnosis and staging, and now at Hoag thanks to philanthropy. “The current approaches to lung cancer diagnosis have some limitations that the new Ion technology can better address, such as the ability to reach peripheral lung nodules. Nearly 70 percent of lung nodules are detected in the outside lung periphery. This new technology provides greater stability to guide a catheter to these outer nodules, paired with superior navigation. I can view my entire pathway to the nodule as I guide the catheter to it,” said Daryl Pearlstein, M.D., program director for lung cancer at Hoag Family Cancer Institute and a board-certified, subspecialty-trained thoracic surgeon.

During an Ion bronchoscopy, a camera leads the catheter to the nodule, remaining steady and adjusting with the patient’s breath. And because it uses robotic technology, rather than a human, to hold in place, the new technology allows the guiding catheter to remain stable and more still. 

In addition to improving access to nodules through stability and navigation, the adoption of this new technology also means an improved experience for patients. “If we could not reach the detected nodule, patients would have to come back for further imaging and biopsy,” continued Dr. Pearlstein. “Other approaches to obtaining a biopsy could also result in a collapsed lung. Utilizing Ion, we enter a patient’s lung in a minimally-invasive fashion, through their mouth into their bronchial tubes.” 

Pearlstein also predicts that the Ion will play a role in treating lung cancer, paving the way for a day when many of the estimated 800 lung cancer patients who come to Hoag each year receive diagnosis, staging and treatment all in one office visit.

“Once you detect lung cancer, the traditional treatment involves removing the entire lobe,” he said. “This technology allows us to mark the nodule with a florescent dye, so we can more easily remove just the segment of the lung that has cancer. To put it in terms of breast cancer, it’s like the difference between doing a lumpectomy, rather than a mastectomy.”

Lung cancer is the second-most common cancer in the U.S. and among the deadliest. Yet, when detected early, lung cancers can be very treatable. 

“In the past, lung cancers were diagnosed at an advance stage, when the prognosis was poor,” Pearlstein said. “Now high-risk individuals are more likely to receive annual CT scans, so more are being successfully treated for lung cancers at earlier stages. Unfortunately, there is still often a two- to three-month delay between when a nodule is noticed on a CT scan and when a diagnosis and determination of a cancer’s stage could be made.”

This new technology promises to reduce that time considerably, improving patients’ prognosis and quality of life.

“Hoag has all the latest treatment modalities for lung cancer: targeted chemotherapy, advanced clinical trials, Cyberknife, robot-assisted surgery. But you can’t treat a tumor until you have a diagnosis and staging,” Pearlstein said. “This technology will allow us to compress the time between detecting a nodule and getting treated. This is such a benefit to the patients.”

While that day is still off in the future, Pearlstein noted that the investment the philanthropic community has made in Hoag brings patients and their families closer to more effective, efficient lung cancer care. Only one other hospital in California has this technology, and few in the nation have the community support that has allowed Hoag to make these types of advances.

For more information: www.hoag.org

Related Content

Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group

Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group. Racial/ethnic groups are mutually exclusive. Data for the non‐Hispanic American Indian/Alaska Native (AI/AN) population are restricted to Indian Health Service Purchased/Referred Care Delivery Area (PRCDA) counties. API indicates Asian/Pacific Islander. Chart courtesy of ACS Journals 

News | Radiation Oncology | March 16, 2020
March 16, 2020 — The Ann...
The low-dose chest computed tomography (CT) scans used in lung cancer screening do not appear to damage human DNA

Immunofluorescent staining performed to depict γ-H2AX foci. Representative images of γ-H2AX foci in peripheral blood lymphocytes in an 82-year-old woman who underwent standard-dose CT. (a) Nuclear DNA of four lymphocytes. (b) γ-H2AX foci (arrows). (c) Markers of DNA double-strand breaks. In this merged image, DNA is blue and γ-H2AX foci are red (arrows show small foci). γ-H2AX, a marker of DNA double-strand breaks, is a phosphorylated type of histone H2AX. Scale bar: 5 mm. Image courtesy of the Radiological Society of North America

News | Lung Cancer | March 11, 2020
March 11, 2020 — The low-dose chest computed tomog...
Pulmonary imaging is important in the diagnosis of the acute lung injury associated with vaping, known as electronic cigarette or vaping product use-associated lung injury (EVALI), according to a special review article published in the journal Radiology

Images show electronic cigarette or vaping product use-associated lung injury in a 32-year-old man with history of vaping who presented with fevers and night sweats for 1 week. (a) Coronal maximum intensity projection image shows diffuse centrilobular nodularity. (b) Histologic sections of his transbronchial cryobiopsy showed distinctive micronodular pattern of airway-centered organizing pneumonia, corresponding to centrilobular nodularity seen at CT. Similar imaging and pathologic findings have been described in patients with smoke synthetic cannabinoids. Image courtesy of Radiological Society of North America (RSNA)

News | Lung Cancer | January 28, 2020
January 28, 2020 — Pulmonary imaging is important in the diagnosis of the acute lung injury associated with...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...
62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

News | PET-CT | November 15, 2019
November 15, 2019 — According to an article published ahead-of-print in the...
This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

News | Clinical Trials | November 08, 2019
November 8, 2019 — As the outbreak of lung injuries and deaths associated with e-cigarettes, or...
Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting from the use of electronic cigarettes (e-cigarettes), or “vaping.”

Image by Lindsay Fox from Pixabay

News | Computed Tomography (CT) | November 06, 2019
November 6, 2019 — Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting
LungPrint Discovery offers fully automatic radiological metrics and unique, time-saving airway visualizations
News | Advanced Visualization | October 29, 2019
October 29, 2019 — VIDA Diagnostics, Inc.
FDA Clears Modules of AI-Rad Companion Chest CT From Siemens Healthineers
Technology | Computed Tomography (CT) | September 26, 2019
The U.S. Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent...